The story
Slovenia’s Medical and Scientific Cannabis Act took effect on 20 August 2025, creating a licensing framework for domestic medical production and scientific work.[1] Parliament adopted it on 24 July, and President Nataša Pirc Musar promulgated it on 1 August.[1]
Medicine access already existed
Doctors had been able to prescribe registered cannabinoid medicines since the 2014 classification change.[2] NIJZ’s report on 2024 medicine consumption describes access through registered medicines, special imports and compounded preparations.[3]
Reporting pharmacies recorded 1,666 prescriptions and 2,091 compounded cannabinoid preparations during 2024, with incomplete coverage of pharmacies.[3] Flower and standardised extracts were permitted, but the report said their prescribing had not entered routine use.[3] Those figures describe the year before the new production law.[3]
Prescribing remained a medical decision
Under the new Act, a doctor may prescribe cannabis medicines for any indication or condition on professional judgment, with at most one month’s treatment per month.[1] Patients need an examination before the first prescription and another after twelve months for continuing treatment.[1]
Dispensing takes place through pharmacies, which issue a certificate documenting authorised possession and use for one month.[1] A patient who gives cannabis dispensed in their name to somebody else faces a €200–€1,000 fine.[1]
Producers needed authorisation
Medical production comes under the medicines agency, JAZMP, with requirements for secure premises, responsible personnel, quality and traceability.[1] Growing and processing operate within that licensed chain, while retail dispensing stays with pharmacies.[1]
The Act separately provides for scientific production, trade and possession under Health Ministry permission.[1] That route covers legal entities conducting research or educational work, with conditions attached to obtaining and using cannabis.[1]
Research applications gained detailed rules
The implementing rules effective on 7 March 2026 require a scientific plan explaining the project’s purpose, methods and goals and the responsible researchers’ credentials.[4] Applicants must document equipment and traceability from seed or planting material through production and study.[4]
Growing projects must follow good agricultural and collection practice, while security plans cover access to the premises.[4] Applicants also need arrangements for destroying material and reporting its disposal.[4] The Slovenia profile follows these licensed medical and scientific routes alongside the separate personal-possession rules.[1][4]
Score by segment 0 to 10
- Possession · 25%3 → 3
- Personal cultivation · 25%1 → 1
- Punishment & enforcement · 20%4 → 4
- Sharing & gifting · 10%1 → 1
- Consumption · 10%2 → 2
- Legal access · 10%1 → 2+1
The bar shows the score after the change; the tick marks where it stood before. The scores after the change are Slovenia's current scores.
References
- Official Gazette — Medical and Scientific Cannabis Act (ZKMZN), 2025Articles 1, 8, 10–15, 24–25, 30–34, 50 and 54archived
- NIJZ and Health Ministry — Cannabis in medicineGovernment decision of 19 June 2014archived
- NIJZ — Prescription medicine consumption in Slovenia in 2024Printed p. 163, cannabinoid preparations and pharmacy returnsarchived
- Official Gazette — Scientific cannabis permit rules, 2026Articles 1–4; published 20 February, effective 7 March 2026archived
- Official Gazette — Medical and Scientific Cannabis Act (ZKMZN), 2025archived
Checked. The date and the event were compared with a source that was read. The score before the change is an editorial estimate.